LexDanaLexDanabeta
Inventor

KENICHIRO TAKAGI

Inventor
JP

Overview

2→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
C12NMicroorganisms or enzymes20%
A01KAnimal husbandry10%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
PatentTitleYear
12,227,563Anti-IGF-I receptor humanized antibody202511,629,194Anti-IGF-I receptor antibodies, encoding nucleic acid molecules and methods of using said antibodies2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to TEIJIN PHARMA LTD (2)· patent assignee history
2023–2025Based in JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
TEIJIN PHARMA LTD22023–2025
Locations
LocationPatentsSpan
JP22023–2025